Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Edit custom filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1995 1
1996 1
1998 2
1999 1
2000 2
2001 4
2002 3
2003 8
2004 3
2005 3
2006 2
2007 5
2008 4
2009 5
2010 4
2011 5
2012 3
2013 5
2014 4
2015 9
2016 6
2017 5
2018 3
2019 1
2020 2
2021 1
2022 3
2023 2
2024 2
2025 2
2026 4

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

95 results

Results by year

Filters applied: . Clear all
Page 1
The Efficacy of Botulinum Toxin A in Treating Palmar Hyperhidrosis - a Literature Review.
Rashaan R, Arkoumanis PT. Rashaan R, et al. Maedica (Bucur). 2023 Dec;18(4):712-717. doi: 10.26574/maedica.2023.18.4.712. Maedica (Bucur). 2023. PMID: 38348073 Free PMC article.
Results:All the six selected studies consistently reported the efficacy of BTX-A in reducing symptoms of hyperhidrosis, without significant side effects. Botulinum toxin type A treatment was found to improve the QoL significantly, to reduce sweat rate and pro …
Results:All the six selected studies consistently reported the efficacy of BTX-A in reducing symptoms of hyperhidrosis, without signi …
Botulinum Toxin Treatment of Autonomic Disorders: Focal Hyperhidrosis and Sialorrhea.
Hosp C, Naumann MK, Hamm H. Hosp C, et al. Semin Neurol. 2016 Feb;36(1):20-8. doi: 10.1055/s-0035-1571214. Epub 2016 Feb 11. Semin Neurol. 2016. PMID: 26866492 Review.
Approval of onabotulinumtoxinA for severe primary axillary hyperhidrosis in 2004 has revolutionized the treatment of this indication. Meanwhile further type A botulinum neurotoxins like abobotulinumtoxinA and incobotulinumtoxinA, as well as the type B botulinum …
Approval of onabotulinumtoxinA for severe primary axillary hyperhidrosis in 2004 has revolutionized the treatment of this indication. …
Botulinum toxin types A and B: comparison of efficacy, duration, and dose-ranging studies for the treatment of facial rhytides and hyperhidrosis.
Yamauchi PS, Lowe NJ. Yamauchi PS, et al. Clin Dermatol. 2004 Jan-Feb;22(1):34-9. doi: 10.1016/j.clindermatol.2003.11.005. Clin Dermatol. 2004. PMID: 15158543 Review.
This article will compare the efficacy, duration, dose ranging studies, and safety in the treatment of facial rhytides with both types of toxins. In addition, the treatment of hyperhidrosis with type-A and type-B botulinum toxin will also be dis …
This article will compare the efficacy, duration, dose ranging studies, and safety in the treatment of facial rhytides with both type …
RimabotulinumtoxinB: An Update.
Song T, Marmur ES. Song T, et al. Dermatol Surg. 2024 Sep 1;50(9S):S52-S57. doi: 10.1097/DSS.0000000000004253. Epub 2024 Jul 1. Dermatol Surg. 2024. PMID: 39196834 Review.
BACKGROUND: Botulinum type-A toxin is a well established aesthetic and medical treatment. While the usage of type-B toxin is less common, there is a growing interest in using type-B toxin, especially in those who are treatment resistant. ...RESULTS: Fa …
BACKGROUND: Botulinum type-A toxin is a well established aesthetic and medical treatment. While the usage of type-B toxin …
Sustained efficacy of botulinum toxin in primary palmar hyperhidrosis: a systematic review of duration, quality of life, and satisfaction.
Eze C, Munoz-Lara S, Whyte T, Jafferany M. Eze C, et al. Front Med (Lausanne). 2026 Mar 25;13:1795512. doi: 10.3389/fmed.2026.1795512. eCollection 2026. Front Med (Lausanne). 2026. PMID: 41958548 Free PMC article.
Botulinum toxin (BoNT) injections are a widely used treatment, but data on their sustained efficacy, impact on QoL, and patient satisfaction remain limited. ...The duration of BoNT efficacy ranged from 3 to 12 months, with BoNT-A demonstrating a mean efficacy …
Botulinum toxin (BoNT) injections are a widely used treatment, but data on their sustained efficacy, impact on QoL, and patien …
Intradermal Botulinum Toxin A Injection Versus Topical 2% Glycopyrrolate for the Treatment of Primary Facial Hyperhidrosis: A Pilot Study and Review of Literature.
Nofal E, Salem S, Khashaba SA. Nofal E, et al. Dermatol Surg. 2022 Aug 1;48(8):843-848. doi: 10.1097/DSS.0000000000003490. Epub 2022 Jun 17. Dermatol Surg. 2022. PMID: 35917265 Review.
RESULTS: Both modalities showed complete response in 75% of cases with a longer duration of action in botulinum toxin group up to 6 months. Side effects were minor and temporary. ...CONCLUSION: Topical glycopyrrolate 2% showed comparable results to Botulin …
RESULTS: Both modalities showed complete response in 75% of cases with a longer duration of action in botulinum toxin g …
Botulinum toxin A for palmar hyperhidrosis.
Wollina U, Karamfilov T. Wollina U, et al. J Eur Acad Dermatol Venereol. 2001 Nov;15(6):555-8. doi: 10.1046/j.1468-3083.2001.00350.x. J Eur Acad Dermatol Venereol. 2001. PMID: 11843216 Clinical Trial.
OBJECTIVE: We evaluated the efficacy and safety of intracutaneous injections of botulinum toxin A on severe palmar hyperhidrosis. METHODS: Ten patients with recalcitrant palmar hyperhidrosis were treated with intercutaneous injections of botulinum …
OBJECTIVE: We evaluated the efficacy and safety of intracutaneous injections of botulinum toxin A on severe palmar hyperhid …
Management of primary plantar hyperhidrosis with botulinum toxin type A: A retrospective case series of 129 patients.
Tsiogka A, Agiasofitou E, Tsimpidakis A, Kontochristopoulos G, Stratigos A, Gregoriou S. Tsiogka A, et al. Australas J Dermatol. 2024 Feb;65(1):49-54. doi: 10.1111/ajd.14188. Epub 2023 Nov 14. Australas J Dermatol. 2024. PMID: 37964488
BACKGROUND/OBJECTIVES: To date, scientific data on the efficacy of botulinum toxin type A (BoNT-A) for primary plantar hyperhidrosis (PPH) are mainly derived from case reports and small case series. ...METHODS: Medical records of patients who were referred to …
BACKGROUND/OBJECTIVES: To date, scientific data on the efficacy of botulinum toxin type A (BoNT-A) for primary plantar hype …
Retrospective analysis of the efficacy and duration of botulinum toxin A injections in 30 patients with palmar hyperhidrosis.
Farrell J, Stewart T, Singh B, Singh G, Rosen R. Farrell J, et al. Intern Med J. 2021 Sep;51(9):1517-1521. doi: 10.1111/imj.15489. Intern Med J. 2021. PMID: 34541778
It has a high morbidity, and a range of treatment options. Botulinum toxin injections inhibit the release of acetylcholine from the presynaptic receptors. It is an effective treatment; however, it is infrequently selected as only axillary hyperhidrosis curren …
It has a high morbidity, and a range of treatment options. Botulinum toxin injections inhibit the release of acetylcholine fro …
Duration of Efficacy Increases with the Repetition of Botulinum Toxin A Injections in Primary Axillary Hyperhidrosis: A 15-year Study in 117 Patients.
Berthin C, Maillard H. Berthin C, et al. Acta Derm Venereol. 2019 Dec 1;99(13):1237-1240. doi: 10.2340/00015555-3307. Acta Derm Venereol. 2019. PMID: 31453629 Free article.
Changes in the duration of efficacy of botulinum toxin A injections for primary axillary hyperhidrosis have not been studied in depth. ...In conclusion, repeated botulinum toxin A injections lead to an increase in duration of effic …
Changes in the duration of efficacy of botulinum toxin A injections for primary axillary hyperhidrosis have not …
95 results